Author:
INKALAGI VINAYAK,KATTI B PRIYANKA
Abstract
Introduction: An independent risk factor for the development of cardiovascular abnormalities may be a little decrease in glomerular filtration rate, since chronic kidney disease (CKD) has a strong correlation with cardiac illnesses. In addition to hastening the course of vascular disease, the combination of risk factors is linked to an increased incidence of ventricular hypertrophy, myocardial fibrosis, valvopathy, arrhythmia, ischemia, and sudden death. When circulatory abnormalities in CKD are identified early, morbidity and mortality can be decreased, and quality of life can be raised.
Aims: The aim of the study was to study cardiac manifestations in CKD.
Methods: The study involved 140 instances of CKD that were admitted to the general medicine department of Al Ameen Medical College in Bijapur, Karnataka.
Results: According to our study, there were 31.4% (44/140) instances of left ventricular hypertrophy (LVH), 13.5% (19/140) of LAD, 18.1% (20/140) of conduction abnormalities, 15.7% (22/140) of ischemia, 2.1% (3/140) of arrhythmias, 2.8% (4/140) of P-mitrale, and 21.4% (30/140) of normal cases.
Conclusion: Echocardiography is a non-invasive, secure, user-friendly, and precise method for evaluating heart function in patients with chronic renal disease. When it comes to identifying LVH, echocardiography is more accurate. When it comes to CKD patients, cardiovascular problems are the main cause of morbidity and death.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference12 articles.
1. US Renal Data System. 2002 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2002.
2. Locatelli F, Marcelli D, Conte F, D’Amico M, Del Vecchio L, Limido A, et al. Cardiovascular disease in chronic renal failure: The challenge continues. Nephrol Dial Transplant 2000;15:69-80.
3. Kundhal K, Lok CE. Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin Pract 2005;101:c47-52.
4. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One 2016;11:e0158765.
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2014:351:1296-305.